pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
ROCHE · news · pharmadog
← back to ROCHE
News mentioning ROCHE
412
stories
11d
Boehringer, Zealand’s obesity drug doesn’t elevate heart risk in key late-stage test
biospace
11d
Ramaswamy’s biotech baggage haunted his political run
biopharma dive
14d
Could we see 10 Chinese Big Pharmas within a decade? Some CEOs think so
fiercebiotech
14d
Novartis reveals cancer cases possibly linked to gene therapy Zolgensma
biopharma dive
15d
Opinion: STAT+: What it’s like to live with cognitively unimpaired Alzheimer’s disease
stat
15d
MedWatch Alert: FDA Investigating Serious Risk of Malignancy Linked to Zolgensma Gene Therapy
fda medwatch
16d
Sanofi stops development of Nurix-partnered immune drug
biopharma dive
16d
Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’
biospace
17d
Sanofi scraps STAT6 degrader from Nurix just 2 months after entering clinic
fiercebiotech
17d
Lonza agrees to buy 5 Merck KGaA facilities to accelerate US expansion
biospace
17d
STAT+: Pharmalittle: We’re reading about a generic HIV prevention shot, Lonza buying U.S. facilities, and more
stat
21d
Assessing Merck and Moderna’s mRNA cancer vaccine
stat
21d
Acumen scraps sole asset after Alzheimer’s fail, plunging stock 80%
biospace
22d
Roche launches differential diagnosis test for mesothelioma
fiercebiotech
23d
STAT+: Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings
stat
23d
STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more
stat
24d
Big Pharma is ready to strike, with J&J most likely to buy: Leerink
biospace
24d
STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
stat
24d
STAT+: RFK Jr. goes for broke in Iowa
stat
24d
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
stat
24d
STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more
stat
24d
A possible treatment for brain-eating amoebas, found in the sea
stat
25d
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
stat
25d
Opinion: Cancer vaccines are finally here. How do we get them to patients?
stat
25d
From RAS rivalries to leaked cancer vaccine readouts, ESMO brought the data drama
fiercebiotech
25d
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
stat
25d
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
stat
25d
Roche’s changing plans show how MFN is complicating European drug launches
endpoints
25d
ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data
biopharma dive
25d
Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs
endpoints
← prev
page 2 of 14
next →